Shoulder Innovations
NYSE: SINorthern California, US · Delaware corporation · 9 known investors
Shoulder Innovations develops InSet® glenoid technology for shoulder joint implants that reduce the rocking horse effect and provide mechanical stability, serving patients with severe shoulder arthritis. The company produces medical devices for orthopedic shoulder procedures.
Founders & leadership
RB
Robert BallCEO & Executive Chairman
MA
Matthew AhearnChief Operating Officer
GP
Geoff PardoDirector
JP
Jeff PointsExecutive Officer
PB
Paul BuckmanDirector
MC
Mike CarusiDirector
KS
Kevin SidowDirector
DB
David BlueExecutive Officer
DR
Don RunningManager and Chief Executive Officer
JO
Jeff OndrlaChief Technology Officer
SG
Stephen GuntherManager
MD
Michael DeVriesManager
Investors · 9
APERTURE Venture PartnersBoston · $1M – $5M
Arboretum VenturesAnn Arbor · $5M – $15M
Genesis Innovation GroupGrand Rapids
Global BrainTokyo · $100K – $184M
Invest MichiganNorthville · $100K – $250K
Lightstone VenturesPortola Valleyvia Mike Carusi · board
US Venture PartnersMenlo Park · $500K – $10Mvia Casey Tansey · board
Wakestream VenturesGrand Rapids · $150K – $500K
WMU Biosciences Research & Commercialization CenterKalamazoo · $100K – $250K
Reported raises · per SEC filings
Form D private placements▶$20.1MraisedMar 2025 · 27 investors · Other Health CareRule 506(b)
▶$20.1MraisedMar 2025 · 27 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Geoff PardoDirector
- Jeff PointsExecutive Officer
- Paul BuckmanDirector
- Mike CarusiDirector
- Kevin SidowDirector
- Matthew AhearnExecutive Officer, Director
- Casey TanseyDirector
- Robert BallExecutive Officer, Director
- David BlueExecutive Officer
- Offering amount
- $40.1M
- Amount sold
- $20.1M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$32.2MraisedFeb 2023 · 21 investors · Other Health CareRule 506(b)
▶$32.2MraisedFeb 2023 · 21 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Casey TanseyDirector
- Mike CarusiDirector
- David BlueExecutive Officer
- Kevin SidowDirector
- Geoff PardoDirector
- Paul BuckmanDirector
- Robert BallExecutive Officer, Director
- Matthew AhearnExecutive Officer, Director
- Offering amount
- $39.8M
- Amount sold
- $32.2M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.5MraisedOct 2022 · 5 investors · Other Health CareRule 506(b)
▶$3.5MraisedOct 2022 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert BallExecutive Officer, Director
- Mike CarusiDirector
- David BlueExecutive Officer
- Matthew AhearnExecutive Officer, Director
- Paul BuckmanDirector
- Kevin SidowDirector
- Casey TanseyDirector
- Offering amount
- $7M
- Amount sold
- $3.5M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$21.6MraisedOct 2020 · 24 investors · Other Health CareRule 506(b)
▶$21.6MraisedOct 2020 · 24 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Matthew AhearnExecutive Officer, Director
- Robert BallExecutive Officer, Director
- David BlueExecutive Officer
- Casey TanseyDirector
- Mike CarusiDirector
- Kevin SidowDirector
- Paul BuckmanDirector
- Offering amount
- $21.6M
- Amount sold
- $21.6M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.2MraisedFeb 2020 · 31 investors · Other Health CareRule 506(b)
▶$2.2MraisedFeb 2020 · 31 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Matthew AhearnExecutive Officer, Director
- Robert BallExecutive Officer, Director
- Ron FrisbieDirector
- Kim PasquinoDirector
- Stephen GuntherDirector
- Offering amount
- $2.2M
- Amount sold
- $2.2M
- Minimum investment
- $1.4K
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.1MraisedNov 2018 · 27 investors · Other Health CareRule 506(b)
▶$5.1MraisedNov 2018 · 27 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Matthew AhearnExecutive Officer, Director
- Stephen GuntherDirector
- Robert BallExecutive Officer, Director
- Offering amount
- $5.6M
- Amount sold
- $5.1M
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$593.9KraisedMar 2016 · 4 investors · Other Health CareRule 506(b)
▶$593.9KraisedMar 2016 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Don RunningDirector
- Michael DeVriesDirector
- Stephen B GuntherDirector
- Robert BallDirector
- Offering amount
- $700K
- Amount sold
- $593.9K
- First sale
- Feb 2016
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$200KraisedMay 2015 · 1 investors · Other Health CareRule 506(b)
▶$200KraisedMay 2015 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Don RunningExecutive Officer, Director
- Jeff OndrlaExecutive Officer
- Robert BallExecutive Officer, Director
- Stephen GuntherDirector
- Michael DeVriesDirector
- Offering amount
- $200K
- Amount sold
- $200K
- Minimum investment
- $200K
- First sale
- Apr 2015
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Shoulder Innovations closes $50M credit facility refinancing By Investing.cominvesting.com · 2026
- Shoulder Innovations Reports First Quarter 2026 Financial Results and Raises Full Year Outlookprnewswire.com · 2026
- Shoulder Innovations Announces Closing of $40 Million Series Eshoulderinnovations.com · 2025
- Shoulder Innovations Revenue Grows 380%, Closes $1.6 Million Investmentgenesisinnovationgroup.com · 2017